LOS ANGELES– BioTools Innovator, a new program focused on accelerating life science tools and diagnostics, today announced the ten companies selected to participate in the organization’s inaugural three-month virtual mentorship-focused Accelerator program. With in-depth, customized mentorship and support from senior industry leaders, finalists will compete for up to $200,000 in non-dilutive cash prizes during the final competition on October 15 in Carlsbad, Calif.
The top ten leading-edge biotechnology startups are developing solutions for cell research, genomics, data and informatics, and synthetic biology and hail from across the U.S. and Europe.
BioTools Innovator’s 2021 Top 10 Accelerator Companies Include:
- Celldom – San Carlos, Calif.
- Clara Biotech – Lawrence, Kan.
- Elemental Machines – Cambridge, Mass.
- Enrich Therapeutics – Branford, Conn.
- EpiCypher – Durham, N.C.
- Glyphic Biotechnologies – Cambridge, Mass.
- Kino Discovery – Irvine, Calif.
- lino Biotech – Zurich
- Machine Bio – Claremont, Calif.
- Stellate DNA – Farmington, Conn.
“Congratulations to the finalists selected for our first BioTools Innovator cohort, an impressive group of cutting-edge life science startups poised to advance research with exciting new innovations,” said Kathryn Zavala, managing director of BioTools Innovator. “We built this Accelerator to support innovators in bringing their promising ideas to market. Together with our partners, we are proud to provide valuable education and expert mentorship to these entrepreneurs working to make a real impact on human health.”
“As a founding partner of BioTools Innovator, we were honored to be part of the selection process for the companies that will participate in the first Accelerator program,” said Shaun Kirkpatrick, president, RCT. “These talented entrepreneurs are developing technologies that could bring significant value to the life science research tools space, and we are eager to help accelerate these products towards commercialization and scale-up.”
“The BioTools Innovator Accelerator cohort are developing products, platforms and services that have the potential to solve unmet needs in the industry,” said Bill Snider, partner, BroadOak Capital Partners. “We look forward to sharing our expertise in helping life science companies grow and succeed with these entrepreneurs, and we look forward to supporting them in their journey to bring new innovations to the market.”
The BioTools Innovator Capstone Event including the Final Competition will be held in Carlsbad, Calif. from October 14-15. Over 160 companies applied for the BioTools program, but only four startups from the 2021 BioTools cohort will advance to compete in the Grand Finals. The winning company, which will be determined by a live audience vote, stands to win a non-dilutive cash prize and the title of the BioTools Innovator 2021 Winner.
BioTools Innovator works closely with stakeholders across the industry to foster the growth of early to mid-stage startups. Funding for BioTools Innovator is provided by the Frederick Gardner Cottrell Foundation of Research Corporation Technologies, Inc. (RCT). Additional support is provided by BroadOak Capital Partners.
